Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

From poor response to low prognosis concept: The new POSEIDON criteria

From poor response to low prognosis concept: The new POSEIDON criteria
  • Reproductive medicine
  • Fertility
International workshop by Excemed
Friday, Oct 13 - Saturday, Oct 14 2017
Athens, Greece

Accreditation

EACCME®

Language

English

Registration status
Closed

Target audiences

Clinicians
embryologists
biologists and scientists working in ART.

Files

Introduction

Access learning resources by clicking the Outcomes tab or scroll down to the Scientific Programme.

Overview

Managing patients with impaired or poor ovarian response (POR) is a controversial issue. Number of oocytes retrieved has been adopted as a criterion of POR in most clinical trials, although the threshold number differs considerably between studies.  A panel of experts (Patient-Oriented Strategies Encompassing Individualized Oocyte Number, the POSEIDON group) recently proposed new criteria to help guide the physician in handling POR patients. This workshop will introduce the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technologies, promote more specific approaches to patients with impaired prognosis during IVF, thereby offering better tools with which to optimize IVF success rates.

Learning objectives

By attending this live educational workshop, participants will be able to:

  • Grasp the state of art regarding definition of impaired response to ovarian stimulation
  • Comprehend the new low prognosis concept and its application in clinical practice
  • Individualize and manage women with expected or unexpected prognosis to ART according POSEIDON classification

Accreditation details

An application has been made to the EACCME ® for CME accreditation of the EXCEMED workshop “From poor response to low prognosis concept: The new POSEIDON criteria ” to be held on 13 -14 October 2017 in Athens, Greece.

Scientific programme

Friday, 13 October 2017

From 09.00     Registration

09.40               Opening

                        R. Fischer, Germany

09.50               Welcome introduction

                        C. Alviggi, Italy

Session I - Poor ovarian response: The relationship between quantity and quality

Chair: R. Fischer, Germany

10.00   L1        Why The POSEIDON classification?  VIDEO LECTURE

                        S. Esteves, Brazil

10.25   L2        What is The POSEIDON classification?  VIDEO LECTURE

                        P. Humaidan, Denmark

10.50               Panel discussion

12.00               Lunch

Session II – From predict to treat

Chair: R. Fischer, Germany

13.15   L3        Markers of ovarian reserve: can we use them for daily clinical practice?

                        A. La Marca, Italy

13.40   L4        The impact of age on oocyte quality  VIDEO LECTURE

                        A. Capalbo, Italy

14.05   L5        The ART Calculator: estimating a new marker of success in ART  VIDEO LECTURE

                        S. Esteves, Brazil

14.30               Panel discussion

16.00               End of the first day

Saturday, 14 October 2017

Session III –Management of The POSEIDON groups

Chair: R. Fanchin, France

08.30   L6        POSEIDON Groups 1 - 2  VIDEO LECTURE

                        C. Alviggi, Italy

08.55   L7        POSEIDON Groups 3 - 4  VIDEO LECTURE

                        P. Humaidan, Denmark

09.20   L8        Strategy of accumulation in The POSEIDON groups  VIDEO LECTURE

                        C. Alviggi, Italy

09.45               Panel discussion

10.45               The POSEIDON website
                         S.C. Esteves (Brazil)

11.00               Coffee break

Session IV – PRACTICAL CASE STUDIES AND DISCUSSION

Chair: R. Fischer, Germany

11.20               Case studies 1-2

                        C. Alviggi, Italy

12.00               Case studies 3-4

                        P. Humaidan, Denmark

12.40               General discussion

13.30               Closing remarks

13.40               End of the workshop

                        Closing lunch

 

CME provider

EXCEMED - Excellence in medical education

Chair(s)

Sandro Esteves

ANDROFERT - Andrology & Human Reproduction Clinic
Campinas, Brazil

Peter Humaidan

Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark
Speakers

Peter Humaidan

Skive Regional Hospital and Faculty of Health
Aarhus University
Fertility Clinic
Skive, Denmark

Sandro Esteves

ANDROFERT - Andrology & Human Reproduction Clinic
Campinas, Brazil

Antonio La Marca

Department of Obstetrics and Gynecology
University of Modena and Reggio Emilia and Clinica Eugin
Modena, Italy

Antonio Capalbo

Biotechnologist Specialist in Medical Genetics, Director of GENETYX Molecular Biology Laboratory
G.EN.E.R.A. Centre for Reproductive Medicine
Rome, Italy

Renato Fanchin

Hospital A. Béclère and University Paris-Sud
Clamart, France
Carlo Alviggi
Reproductive medicine
Slide kit
Carlo Alviggi
Reproductive medicine
Carlo Alviggi
Reproductive medicine
Slide kit
Carlo Alviggi
Reproductive medicine
Slide kit
Carlo Alviggi
Reproductive medicine
Slide kit
Antonio Capalbo
Reproductive medicine
Antonio Capalbo
Reproductive medicine
Slide kit
Sandro Esteves
Reproductive medicine
Video
Sandro Esteves
Reproductive medicine
Slide kit
Sandro Esteves
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine
Peter Humaidan
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine
Peter Humaidan
Reproductive medicine
Slide kit
Peter Humaidan
Reproductive medicine
Slide kit
Antonio La Marca
Reproductive medicine